Abstract:You have accessJournal of UrologyCME1 Apr 2023PD10-08 THE PROGNOSTIC IMPACT OF PREOPERATIVE PSMA-PET ON EARLY ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A MULTI-CENTER ANALYSIS Simone Scuderi, Giorgio Gandaglia, Armando Stabile, Armando Stabile, Elio Mazzone, Francesco Barletta, Nicolai Huebner, Eugenio Brunocilla, Agostino Mattei, Luca Afferi, Shahrok Shariat, Giancarlo Marra, Junlong Zhuang, Hongqian Guo, Riccardo Schiavina, Lorenzo Bianchi, Fabio Zattoni, Giuseppe Reitano, Pawel Rajwa, Juan Gomez Rivas, Claudia Kesch, Enrico Checcucci, Francesco Porpiglia, Edoardo Cisero, Daniele Amparore, Maria Picchio, Francesco Montorsi, and Alberto Briganti Simone ScuderiSimone Scuderi More articles by this author , Giorgio GandagliaGiorgio Gandaglia More articles by this author , Armando StabileArmando Stabile More articles by this author , Armando StabileArmando Stabile More articles by this author , Elio MazzoneElio Mazzone More articles by this author , Francesco BarlettaFrancesco Barletta More articles by this author , Nicolai HuebnerNicolai Huebner More articles by this author , Eugenio BrunocillaEugenio Brunocilla More articles by this author , Agostino MatteiAgostino Mattei More articles by this author , Luca AfferiLuca Afferi More articles by this author , Shahrok ShariatShahrok Shariat More articles by this author , Giancarlo MarraGiancarlo Marra More articles by this author , Junlong ZhuangJunlong Zhuang More articles by this author , Hongqian GuoHongqian Guo More articles by this author , Riccardo SchiavinaRiccardo Schiavina More articles by this author , Lorenzo BianchiLorenzo Bianchi More articles by this author , Fabio ZattoniFabio Zattoni More articles by this author , Giuseppe ReitanoGiuseppe Reitano More articles by this author , Pawel RajwaPawel Rajwa More articles by this author , Juan Gomez RivasJuan Gomez Rivas More articles by this author , Claudia KeschClaudia Kesch More articles by this author , Enrico CheccucciEnrico Checcucci More articles by this author , Francesco PorpigliaFrancesco Porpiglia More articles by this author , Edoardo CiseroEdoardo Cisero More articles by this author , Daniele AmparoreDaniele Amparore More articles by this author , Maria PicchioMaria Picchio More articles by this author , Francesco MontorsiFrancesco Montorsi More articles by this author , and Alberto BrigantiAlberto Briganti More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003250.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: PSMA-PET in prostate cancer (PCa) staging is associated with higher accuracy for nodal and metastatic detection than conventional imaging. Clinical guidelines still do not recommend PSMA-PET before radical prostatectomy (RP). We hypothesized that the implementation of PSMA PET in the preoperative staging pathway is associated with better patient risk stratification and early cancer control. METHODS: We relied on 3,978 N0M0 PCa patients treated with RP +/- extended pelvic nodal dissection between 2010 and 2022. 3,518 men staged with conventional imaging were identified in a single institution dataset (Group 1). Additional 278 patients with available details both on PSMA PET and CT scans were identified from a multi-institutional cohort of men staged with PSMA-PET (Group 2). Early recurrence was defined as PSA persistence (first postoperative PSA ≥0.1 ng/ml) or PSA rise ≥0.2 ng/ml within 1 year after RP. Multivariable logistic regressions (MLR) tested the impact of the preoperative imaging on early recurrence. MLR models tested for predictor status of PET-PSMA and CT-scan after adjusting for PSA, biopsy grade group and non-organ-confined (NOC) disease at mpMRI. Accuracy of MLR models containing PET-PSMA (model 1) and CT-scan (model 2) were assessed with the ROC-derived AUC. Decision-curve analyses (DCA) assessed the net benefit associated with the use of the two models. RESULTS: 282 patients experienced early recurrence. Patients in Group 2 had higher preoperative PSA values (8.5 vs. 6.4 ng/mL) and higher rates of biopsy grade group (GG) >3 (57% vs. 11%, all p<0.01) compared to Group 1. Early BCR rates were similar between the two groups (12% vs. 10% for group 2 and group 1, respectively, p=0.3). At MLR, being staged with PSMA-PET was associated with a lower risk of early recurrence (OR 0.61, p=0.01) after accounting for PSA, clinical stage, and biopsy ISUP GG. Focusing on men with available PSMA-PET and CT, the presence of positive PET-PSMA (OR: 4.34, p=0.004) but not CT-scan predicted early recurrence. The discrimination was higher for model 1 including PSMA-PET compared to model 2 (73 vs 67%). The adoption of model 1 including PSMA-PET was associated with a higher net benefit as compared to model 2. CONCLUSIONS: Non-metastatic PCa patients staged with PSMA PET scan are at lower risk of early recurrence when compared to those staged with conventional imaging alone. PSMA PET scan helps clinicians to improve preoperative risk stratification and to the identification of men who might benefit most from treatments. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e329 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Simone Scuderi More articles by this author Giorgio Gandaglia More articles by this author Armando Stabile More articles by this author Armando Stabile More articles by this author Elio Mazzone More articles by this author Francesco Barletta More articles by this author Nicolai Huebner More articles by this author Eugenio Brunocilla More articles by this author Agostino Mattei More articles by this author Luca Afferi More articles by this author Shahrok Shariat More articles by this author Giancarlo Marra More articles by this author Junlong Zhuang More articles by this author Hongqian Guo More articles by this author Riccardo Schiavina More articles by this author Lorenzo Bianchi More articles by this author Fabio Zattoni More articles by this author Giuseppe Reitano More articles by this author Pawel Rajwa More articles by this author Juan Gomez Rivas More articles by this author Claudia Kesch More articles by this author Enrico Checcucci More articles by this author Francesco Porpiglia More articles by this author Edoardo Cisero More articles by this author Daniele Amparore More articles by this author Maria Picchio More articles by this author Francesco Montorsi More articles by this author Alberto Briganti More articles by this author Expand All Advertisement PDF downloadLoading ...

Mpmri of the Prostate in Patients Carrying a High Clinical Risk of Prostate Cancer Diagnosis: is This Imaging Test Necessary for Diagnostic Purposes in This Subset of Patients?

Optimizing Detection and Prediction of Prostate Cancer after Positive MRI and Negative Biopsies

Has the Introduction of Multiparametric Magnetic Resonance Imaging of the Prostate and Targeted Biopsies Led to a Risk of Overgrading of High Risk Prostate Cancer? Results from a Contemporary, Large Multi-Institutional Series

The Impact of Multiple Lesions in Prostate MRI – Insights from the YAU Prostate Cancer Group

MP20-04 FEASIBILITY AND ACCURACY OF TRANSPERINEAL FREE-HAND MPMRI TARGETED PROSTATE BIOPSIES UNDER LOCAL ANESTHESIA: A MULTICENTER PROSPECTIVE COHORT OF 1,014 PATIENTS

The Significant Added Value of Concomitant Systematic Prostate Biopsies in Addition to Targeted Sampling in Patients with Previous Negative Biopsies. Implications for Accurate Staging Predictions from a Large Multi-Institutional Series

ROLE OF PREBIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR PROSTATE CANCER DIAGNOSIS IN BIOPSY-NAIVE MEN: A LITERATURE BASED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

MP30-15 THE COMBINATION OF PROSTATE HEALTH INDEX (PHI) AND MULTIPARAMETRIC MRI PROSTATE IMPROVES THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA): A MULTICENTRE EVALUATION

Transrectal Ultrasound Examination of Prostate Cancer Guided by Fusion Imaging of Multiparametric MRI and TRUS: Avoiding Unnecessary Mpmri-Guided Targeted Biopsy

Integrating Index Lesion Volume to Better Classify Men with Indolent Prostate Cancer among Patients with Intermediate Risk Disease. Results from a Large, Multi-Institutional Series

When Does Systematic Biopsy Information Matter the Most? Identifying Independent Predictors of Disease Downgrading at Radical Prostatectomy in High Grade Prostate Cancer Based on a Large Multi-Institutional Series

Improving Prediction of Local Stage by PSMA-PET: Development of a Novel Integrated Tool for Extracapsular Extension and Seminal Vesicle Invasion Combining Clinical and Imaging Features in Localized Prostate Cancer

The Role of Systematic Biopsy in the Era of MRI Guided Prostate Biopsy in a Multi-Centre Asian Cohort

Multivariable stratification of PI-RADS version 2.1 categories for the risk of false-positive target biopsy: Impact on prostate biopsy decisions

A Clinical Available Decision Support Scheme for Optimizing Prostate Biopsy Based on Mpmri

MP16-15 THE DIAGNOSTIC ROLE OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING BEFORE INITIAL PROSTATE BIOPSY: THE DEVELOPMENT OF NOMOGRAMS PREDICTING THE OUTCOMES OF PROSTATE BIOPSY

MP74-16 AVOIDING UNNECESSARY PROSTATE BIOPSY TO DETECT PRIMARY PROSTATE CANCER: THE NON-INVASIVE DIAGNOSIS VALUE OF 68 GA-PSMA PET/CT-BASED RADIOMICS ANALYSIS WITH MACHINE LEARNING

MP03-01 MAGNETIC RESONANCE IMAGING-GUIDED PROSTATE BIOPSIES FAIL TO OUTPERFORM STANDARD TRANSRECTAL ULTRASOUND-GUIDED BIOPSY IN DETECTING HIGH-RISK PROSTATE CANCER: A BAYESIAN NETWORK META-ANALYSIS OF 24 RANDOMISED CONTROLLED TRIALS

The Prognostic Impact of Preoperative Psma-Pet on Early Oncological Outcomes in Prostate Cancer Patients Treated with Radical Prostatectomy: Results of a Multi-Center Analysis

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System

Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial)